Literature DB >> 17453028

Pharmacological approaches to the management of pain in the neonatal intensive care unit.

K J S Anand1.   

Abstract

Effective and consistent management of neonatal pain remains a controversial issue. Premature infants are repeatedly subjected to painful tests and procedures or suffer painful conditions when they are most vulnerable. With different mechanisms transducing various types of pain the practice of 'one-drug fits all' becomes questionable. Clinicians must use the latest non-pharmacologic and pharmacologic therapies for effective management of neonatal pain, distress, or agitation. Pharmacologic strategies for dealing with neonatal pain in the neonatal intensive care unit are described. Opioid therapy, once considered the mainstay for neonatal analgesia, may not be as effective as previously thought. Morphine infusions do not alter the neurological outcomes of preterm neonates and may not be effective against acute pain. Alternative approaches with methadone, ketamine, or local anesthetics should be considered. Clinicians must understand the contextual circumstances underlying pain in individual neonates and tailor therapy accordingly, using the most current evidence related to neonatal pain assessment and management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453028     DOI: 10.1038/sj.jp.7211712

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  19 in total

1.  The Neonatal Pain, Agitation and Sedation Scale and the bedside nurse's assessment of neonates.

Authors:  B A Hillman; M N Tabrizi; E B Gauda; K A Carson; S W Aucott
Journal:  J Perinatol       Date:  2014-08-21       Impact factor: 2.521

Review 2.  Anesthesia and analgesia in the NICU.

Authors:  R Whit Hall
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

3.  Methadone toxicity and possible induction and enhanced elimination in a premature neonate.

Authors:  Mathew George; Joseph P Kitzmiller; Michele Burns Ewald; Katherine A O'Donell; Melissa Lai Becter; Steve Salhanick
Journal:  J Med Toxicol       Date:  2012-12

4.  Neonatal morphine exposure in very preterm infants-cerebral development and outcomes.

Authors:  Rachel Steinhorn; Christopher McPherson; Peter J Anderson; Jeffrey Neil; Lex W Doyle; Terrie Inder
Journal:  J Pediatr       Date:  2015-05       Impact factor: 4.406

Review 5.  Pain management in newborns: from prevention to treatment.

Authors:  Elizabeth Walter-Nicolet; Daniel Annequin; Valerie Biran; Delphine Mitanchez; Barbara Tourniaire
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

6.  Honokiol for the Treatment of Neonatal Pain and Prevention of Consequent Neurobehavioral Disorders.

Authors:  Anna Woodbury; Shan Ping Yu; Dongdong Chen; Xiaohuan Gu; Jin Hwan Lee; James Zhang; Alyssa Espinera; Paul S García; Ling Wei
Journal:  J Nat Prod       Date:  2015-11-05       Impact factor: 4.050

7.  S-Methadone augments R-methadone induced respiratory depression in the neonatal guinea pig.

Authors:  Daniel A N Silverman; Rosemary T Nettleton; Katherine B Spencer; Michael Wallisch; George D Olsen
Journal:  Respir Physiol Neurobiol       Date:  2009-09-08       Impact factor: 1.931

8.  Drugs of choice for sedation and analgesia in the neonatal ICU.

Authors:  R Whit Hall; Rolla M Shbarou
Journal:  Clin Perinatol       Date:  2009-03       Impact factor: 3.430

9.  To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial.

Authors:  P Thakkar; K Arora; K Goyal; R R Das; B Javadekar; S Aiyer; S K Panigrahi
Journal:  J Perinatol       Date:  2015-11-19       Impact factor: 2.521

10.  Ketamine suppresses hypoxia-induced inflammatory responses in the late-gestation ovine fetal kidney cortex.

Authors:  Eileen I Chang; Miguel A Zárate; Maria B Rabaglino; Elaine M Richards; Maureen Keller-Wood; Charles E Wood
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.